Ovid Therapeutics Promotes Charles Carter to Chief Financial Officer in Leadership Shuffle

Ovid Therapeutics shook up its leadership, including by promoting Charles Carter to the role of finance chief and hiring Kevin Norrett as chief business officer, as the biopharmaceutical company ...

Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development

Kevin Norrett, a proven leader in advancing corporate strategy through value-creating transactions, will be appointed as Chief Business ...
DonanımHaber

Codexis (CDXS) Surges 4.89% as Shares Test Key Resistance at $2.48 - AAII Bearish

Codexis (CDXS) stock outlook | valuation trends and trading momentum remain in focus. Codexis Inc. (CDXS) closed at $2.36, ...

Codexis Shareholders Back Board Slate and Governance Measures

Codexis, Inc. held its 2026 Annual Meeting of Stockholders on June 17, 2026, where shareholders elected directors Stephen G. Dilly, Raymond De Vré and Rahul Singhvi to three-year terms expiring at the ...